20 / 20
Page 50
Notes:
allied
academies
March 07-08, 2019 | London, UK
Journal of Diabetology | Volume 3
Annual Summit on
Diabetes, Obesity & Heart
Diabetes, Endocrinology and Metabolic Syndrome
International Conference on
Joint Event
&
Challenges and novel applications for biomarkers and new technologies: Positioning diabetes
research in the 4th industrial revolution
Etheresia Pretorius
Stellenbosch University, South Africa
A
strong correlation exists between type 2 diabetes mellitus
(T2DM) and cardiovascular disease (CVD), with CVD and
the presence of atherosclerosis being the prevailing cause of
morbidity and mortality in diabetic populations. T2DM is joined
by different coagulopathies, including atypical clot development
oramyloidfibrin,andtheexistenceofdysregulatedinflammatory
particles, andbloodplatelets, includingblood cells areespecially
vulnerable, to these dysregulated inflammatory cytokines.
Although T2DM is arguably, the most studied condition, the
prevalence has now reached staggering levels, with a steady
increase also in developing countries. Researchers therefore
need to look at novel technologies and biomarkers to address
the T2DM pandemic. We should therefore actively participate
and use technologies from the 4th industrial revolution, which
is characterized by a fusion of technologies that is blurring
the lines between the digital, physical and biological spheres,
collectively referred to as cyber-physical systems. In this talk, I
will discuss novel biomarkers, as well as point-of-care devices
for early identification of T2DM, the use of bigmachine learning
to find disease, inflection points, leading to the ultimate goal in
T2DM, that of both personalized and precision medicine.
e:
resiap@sun.ac.za